[Skip to Content]
English | Français
Times are displayed in (UTC-04:00) Eastern Time (US & Canada) Change
Add to Google | Outlook | iCalendar

5/31/2024 | 11:15 AM – 12:45 PM

Glaucoma I: Medical / Glaucome I: Médical

Description

Moderator(s): Robert Schertzer
Fayçal Mokhtari

Learning Objectives

At the end of this session, participants will be able to:

1. Understand medication persistence rates and corneal glaucoma surgical risk factors.

2. Explore the relationship of blood pressure and molecular profiles in glaucoma.

3. Integrate interpreting challenging OCT images and ergonomic changes into your practice.

 

CanMEDS: Medical Expert, Scholar

 

Target Audience: Comprehensive, Residents/Fellows, Medical Students, allied health, glaucoma specialists, and other specialists interested in glaucoma all work.

 

des objectifs d'apprentissage

À la fin de la séance, les participants pourront,

1. Comprendre les taux de persistance des médicaments et les facteurs de risque chirurgicaux du glaucome cornéen.

2. Explorer le lien entre la pression artérielle et les profils moléculaires dans le glaucome.

3. Intégrer l’interprétation des images de TCO complexes et les changements ergonomiques dans votre pratique.

 

CanMEDS: Expert medical, Érudit

 

Public cible: Ophtalmologistes généralistes, résidents/boursiers, étudiants en médecine, Professionnels de la santé alliés, les spécialistes du glaucome et d'autres spécialistes intéressés par le glaucome travaillent tous.

Presentations

Glaucoma Medication Persistence Rates in Ontario – A Population Study

11:15 AM - 11:22 AM

Presenting Author: Tianwei Ellen Zhou


Additional Author(s):

Zhengjing Jimmy Hu, Trillium Health Partners

Michael Yang, Prism Eye Institute

Marko Popovic, Department of Ophthalmology & Vision Sciences, University of Toronto

Laura Rosella, Trillium Health Partners, Temerty Faculty of Medicine (University of Toronto)

Matthew Schlenker, Department of Ophthalmology & Vision Sciences, University of Toronto


See Details

Impact of age, corneal thickness, intraocular pressure, and preoperative use of topical carbonic anhydrase inhibitors on rates of corneal decompensation requiring corneal graft in patients with Ahmed or Baerveldt implants.

11:32 AM - 11:39 AM

Presenting Author: Rayan Tolba


Additional Author(s):

Aaron Xu, Université Laval

Laurence Bussières, Université Laval

Mélanie Hébert, Université Laval

Caroline Lajoie, Université Laval


See Details

Q&A

11:49 AM - 12:00 PM


See Details

Molecular profiles in different stages of primary open angle glaucoma – a prospective study

12:10 PM - 12:17 PM

Presenting Author: Tianwei Ellen Zhou


Additional Author(s):

David Mathew, Toronto Western Hospital

Karen Wigg, University Health Network

Carmen Balian, Kensington Eye Institute

Irfan Kherani, University Health Network

Matthew Schlenker, University Health Network

Jeremy Sivak, University Health Network


See Details

How Prostaglandin Analogues and the PTGFR do the (PRESTO-) Tango

12:27 PM - 12:34 PM

Presenting Author: Nicole Costanzo


Additional Author(s):

Nicholas Bel, Lakehead University

Neelam Khaper, Northern Ontario School of Medicine University

Sanjoy Gupta, Northern Ontario School of Medicine University


See Details

Q&A

12:34 PM - 12:45 PM


See Details

Glaucoma I: Medical / Glaucome I: Médical

Description

Date: Friday May 31
Time: 11:15 AM to 12:45 PM
Room: Room | Salle 801
Session Chair: Raj Bindlish, Rob Schertzer

Back to Sessions Gallery